Aamer Khan, Pharm.D., MBA

Senior Director, Field Medical Affairs
Kiniksa Pharmaceuticals

Poster(s):

• (30) Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry
  Wednesday, October 29, 2025